Skip to content
Screener

National Health Investors NHI Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$89.8MMiss by $5.3M
EPS$1.32Beat by $0.08
Revenue estimate$95.1M
EPS estimate$1.24

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$68.5M
EPS estimate$1.16

Financials

Q3 2025

Income statement

See full
Revenue$89.8M+8.3%
Net income$32.9M+15.1%
EPS (diluted)$0.69+6.2%

Balance sheet

See full
Cash & equivalents$81.6M+359%
Total debt$1.1B-24.1%
Total equity$1.5B+20.5%
Total assets$2.7B+9.3%

Cash flow

See full
Operating cash flow$62.5M+28.6%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$3.77B+3.5%
Enterprise value$4.8B-5.7%
P/E25.6×-3.1×
P/S10.6×-0.5×

Profitability

See full
Net margin41.4%+2.9pp

Returns & leverage

See full
Return on equity10.9%+0.7pp
Debt / equity0.7×-0.4×

Segments

By segment

See full
Investments$68.6M-0.6%
SHOP$21.2M+53.8%

FAQ

When did National Health Investors report Q3 2025 earnings?
National Health Investors (NHI) reported Q3 2025 earnings on November 6, 2025 after market close.
What were National Health Investors's Q3 2025 revenue and EPS?
National Health Investors reported revenue of $89.8M and eps of $1.32 for Q3 2025.
Did National Health Investors beat estimates in Q3 2025?
Revenue missed the consensus estimate of $95.1M by $5.3M. EPS beat the consensus estimate of $1.24 by $0.08.
How did National Health Investors's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.3% from $82.9M a year earlier and eps grew 28.2% from $1.03.
Where can I find National Health Investors's Q3 2025 SEC filings?
You can read the 8-K earnings release (0000877860-25-000189) and the 10-Q periodic report (0000877860-25-000183) directly on SEC EDGAR. The filing index links above go to sec.gov.